ProQR Therapeutics (PRQR) Current Assets (2013 - 2026)

ProQR Therapeutics has reported Current Assets for 14 years, with the latest figure at $101.8 million in Q1 2026.

• Quarterly Current Assets fell 29.89% year-over-year to $101.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $101.8 million (down 29.89% YoY) and the FY2025 annual result came in at $116.6 million, down 29.1% from the prior year.
• Current Assets retreated to $101.8 million in Q1 2026 per PRQR's latest filing, from $116.6 million in the prior quarter.
• Over five years, Current Assets peaked at $193.6 million in Q1 2022 and troughed at $101.5 million in Q3 2024.
• A 5-year average of $136.2 million and a median of $135.7 million in 2023 frame the typical range for Current Assets.
• The widest YoY moves for Current Assets: up 220132.99% in 2022, down 49.73% in 2022.
• Over 5 years, Current Assets stood at $157.6 million in 2022, then decreased by 17.4% to $130.2 million in 2023, then increased by 26.29% to $164.4 million in 2024, then retreated by 29.1% to $116.6 million in 2025, then fell by 12.63% to $101.8 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $101.8 million, $116.6 million, and $130.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.